Resilient Data Futures
SourceS-0081

PDB and FDA cancer drug approvals 2019-2023

References [81]2026-05-030 out · 1 in

100% of 34 new United States Food and Drug Administration-approved low-molecular-weight, protein-targeted cancer drugs between 2019 and 2023 relied on Protein Data Bank data.

Use: E-0050.

Original whitepaper reference: [81]